TY - JOUR
T1 - Human heredity and health (H3) in africa kidney disease research network
T2 - A focus on methods in sub-Saharan Africa
AU - Osafo, Charlotte
AU - Raji, Yemi Raheem
AU - Burke, David
AU - Tayo, Bamidele O.
AU - Tiffin, Nicki
AU - Moxey-Mims, Marva M.
AU - Rasooly, Rebekah S.
AU - Kimmel, Paul L.
AU - Ojo, Akinlolu
AU - Adu, Dwomoa
AU - Parekh, Rulan S.
PY - 2015/12/7
Y1 - 2015/12/7
N2 - CKD affects an estimated 14% of adults in sub-Saharan Africa, but very little research has been done on the cause, progression, and prevention of CKD there. As part of the Human Heredity and Health in Africa (H3Africa) Consortium, the H3Africa Kidney Disease Research Network was established to study prevalent forms of kidney disease in sub-Saharan Africa and increase the capacity for genetics and genomics research. The study is performing comprehensive phenotypic characterization and analyzing environmental and genetic factors from nine clinical centers in four African countries (Ghana, Nigeria, Ethiopia, and Kenya) over a 5-year period. Approximately 4000 participants with specified kidney disease diagnoses and 4000 control participants will be enrolled in the four African countries. In addition, approximately 50 families with hereditary glomerular disease will be enrolled. The study includes both pediatric and adult participants age
AB - CKD affects an estimated 14% of adults in sub-Saharan Africa, but very little research has been done on the cause, progression, and prevention of CKD there. As part of the Human Heredity and Health in Africa (H3Africa) Consortium, the H3Africa Kidney Disease Research Network was established to study prevalent forms of kidney disease in sub-Saharan Africa and increase the capacity for genetics and genomics research. The study is performing comprehensive phenotypic characterization and analyzing environmental and genetic factors from nine clinical centers in four African countries (Ghana, Nigeria, Ethiopia, and Kenya) over a 5-year period. Approximately 4000 participants with specified kidney disease diagnoses and 4000 control participants will be enrolled in the four African countries. In addition, approximately 50 families with hereditary glomerular disease will be enrolled. The study includes both pediatric and adult participants age
UR - http://www.scopus.com/inward/record.url?scp=84957800409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957800409&partnerID=8YFLogxK
U2 - 10.2215/CJN.11951214
DO - 10.2215/CJN.11951214
M3 - Article
C2 - 26138261
AN - SCOPUS:84957800409
SN - 1555-9041
VL - 10
SP - 2279
EP - 2287
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 12
ER -